Trupanion, Inc. (NASDAQ:TRUP) Receives Average Recommendation of “Moderate Buy” from Analysts

Trupanion, Inc. (NASDAQ:TRUP) has been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $44.67.

Several equities analysts have recently commented on the stock. Stifel Nicolaus boosted their price target on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Piper Sandler upped their target price on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Northland Securities lifted their price target on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Finally, Bank of America increased their price objective on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th.

Trupanion Stock Performance

TRUP opened at $49.79 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The firm has a market cap of $2.11 billion, a PE ratio of -155.59 and a beta of 1.60. The business has a fifty day simple moving average of $52.83 and a 200-day simple moving average of $42.48. Trupanion has a fifty-two week low of $19.69 and a fifty-two week high of $57.90.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The business had revenue of $327.50 million for the quarter, compared to analyst estimates of $321.79 million. During the same quarter in the previous year, the business earned ($0.10) earnings per share. The firm’s revenue was up 14.6% compared to the same quarter last year. As a group, equities analysts predict that Trupanion will post -0.23 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Murray B. Low sold 2,000 shares of Trupanion stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total value of $105,340.00. Following the transaction, the director now directly owns 131,513 shares in the company, valued at approximately $6,926,789.71. The trade was a 1.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 9,867 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $53.08, for a total value of $523,740.36. The disclosure for this sale can be found here. Insiders sold 28,405 shares of company stock valued at $1,512,482 over the last 90 days. 5.50% of the stock is currently owned by company insiders.

Institutional Trading of Trupanion

A number of institutional investors and hedge funds have recently modified their holdings of TRUP. Quest Partners LLC acquired a new position in Trupanion in the third quarter worth about $37,000. Wilmington Savings Fund Society FSB bought a new position in shares of Trupanion during the 3rd quarter worth approximately $54,000. GAMMA Investing LLC boosted its stake in Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after buying an additional 596 shares in the last quarter. Headlands Technologies LLC acquired a new position in Trupanion during the second quarter worth $162,000. Finally, Entropy Technologies LP acquired a new stake in shares of Trupanion in the 3rd quarter valued at $202,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.